|Online Slide/Audio Symposium|
Satellite Symposium of the American Society of Nephrology 30th Annual Scientific Meeting,
Schein Pharmaceutical, ASN Corporate Sponsor
Supported by an unrestricted grant from Schein Pharmaceutical
NKF-DOQI Anemia Guidelines: Changing Clinical Practice Through Evidence and Experience
Opening Remarks: Development of the NKF-DOQI Guidelines
Garabed Eknoyan, M.D.
Changing Clinical Practice Through Evidence and Experience: DOQI targets for anemia.
Joseph W. Eschbach, M.D., Program Chairperson
Iron, Ferritin, and Infection: Cause or Effect?
John W. Adamson, M.D.
Elevated Iron Indices vs. Iron Overload: Role of Monitoring and Surveillance
John C. Stivelman, M.D.
Subcutaneous rHuEPO administration: What is the controversy?
Jeffrey S. Berns, M.D.
Applying the Anemia Guidelines: Risk/Benefit Analysis
Jay B. Wish, M.D.
Questions and Answers
Drs. Eschbach, Adamson, Stivelman, Berns, and Wish
Comments, new questions, and opinions
General comments regarding anemia guidelines
John W. Adamson, M.D.,
Director of Research, Lindsley F. Kimbal Research Institute, New York Blood
Center, New York, NY
Jeffrey S. Berns, M.D., Clinical Associate Professor of Medicine, Allegheny University Hospital, Graduate, Philadelphia, PA
Garabed Eknoyan, M.D., Professor of Medicine, Baylor College of Medicine, Houston, TX; President, National Kidney Foundation, NKF-DOQI Co-Chair
Joseph Eschbach, M.D., Chair, Clinical Professor of Medicine, University of Washington Minor and James Medical, Seattle, WA
John C. Stivelman, M.D., Associate Professor of Medicine, Emory University Medical Center, Atlanta, GA
Jay B. Wish, M.D., Professor of Medicine, Case Western University, Medical Director, Hemodialysis Unit, University Hospitals of Cleveland, Cleveland, OH
Back to symposia list by topic
Back to symposia list by meeting
Back to HDCN home page